| Darryl Macias, MD | |
|
Rehoboth Mckinley Christian Health Care Services, 1901 Red Rock Drive, Gallup, NM 87301 | |
| (505) 863-7000 | |
| Not Available |
| Full Name | Darryl Macias |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 33 Years |
| Location | Rehoboth Mckinley Christian Health Care Services, Gallup, New Mexico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194797779 | NPI | - | NPPES |
| 16592 | Medicaid | NM | |
| NM007580 | Other | NM | BCBS |
| PROVP14220 | Other | NM | MOLINA |
| 176207 | Medicaid | AZ | |
| 201006171 | Other | NM | PRESBYTERIAN HEALTH/SALUD |
| P00200863 | Other | RAILROAD MEDICARE | |
| 10001036 | Other | NM | LOVELACE HEALTH/SALUD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 93-319 (New Mexico) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Timothy D Peterson, Md Pc | 5799805040 | 5 |
News Archive
Hard to Treat Diseases, Inc. subsidiary, Shenzhen Mellow Hope Pharm Industrial Co., Ltd. (Mellow Hope) announced today that the general manager of Mellow Hope paid a visit to Chile, in regards to a significant new business development opportunity related to Mellow Hope's MedVac flu vaccine products. The company intends to participate in a formal tender process to supply a couple separate orders to a couple separate and unrelated entities in Chile.
Medsphere Systems Corporation, the leading provider of open-source healthcare enterprise solutions, today voiced support for the official "meaningful use" requirements released by the Department of Health and Human Services' Office of the National Coordinator for Health IT. These recently announced requirements will be used to determine hospitals' eligibility for millions in American Recovery and Reinvestment Act stimulus funds associated with deploying health IT solutions to improve patient care.
The National Association For Continence (NAFC) is heading a newly formed council with the objective of establishing national, independent quality standards for disposable adult absorbent products provided by states to Medicaid waiver recipients cared for in their private homes rather than as residents of a state-funded nursing home.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that it has granted Novartis an option to obtain an exclusive worldwide license to develop and commercialize its p53 temporary inhibitor siRNA drug QPI-1002, currently the subject of a Phase II clinical trial.
› Verified 4 days ago
| Entity Name | Unm Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831218627 PECOS PAC ID: 4981795267 Enrollment ID: O20070801000589 |
News Archive
Hard to Treat Diseases, Inc. subsidiary, Shenzhen Mellow Hope Pharm Industrial Co., Ltd. (Mellow Hope) announced today that the general manager of Mellow Hope paid a visit to Chile, in regards to a significant new business development opportunity related to Mellow Hope's MedVac flu vaccine products. The company intends to participate in a formal tender process to supply a couple separate orders to a couple separate and unrelated entities in Chile.
Medsphere Systems Corporation, the leading provider of open-source healthcare enterprise solutions, today voiced support for the official "meaningful use" requirements released by the Department of Health and Human Services' Office of the National Coordinator for Health IT. These recently announced requirements will be used to determine hospitals' eligibility for millions in American Recovery and Reinvestment Act stimulus funds associated with deploying health IT solutions to improve patient care.
The National Association For Continence (NAFC) is heading a newly formed council with the objective of establishing national, independent quality standards for disposable adult absorbent products provided by states to Medicaid waiver recipients cared for in their private homes rather than as residents of a state-funded nursing home.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that it has granted Novartis an option to obtain an exclusive worldwide license to develop and commercialize its p53 temporary inhibitor siRNA drug QPI-1002, currently the subject of a Phase II clinical trial.
› Verified 4 days ago
| Entity Name | Timothy D Peterson, Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073818555 PECOS PAC ID: 5799805040 Enrollment ID: O20111207000472 |
News Archive
Hard to Treat Diseases, Inc. subsidiary, Shenzhen Mellow Hope Pharm Industrial Co., Ltd. (Mellow Hope) announced today that the general manager of Mellow Hope paid a visit to Chile, in regards to a significant new business development opportunity related to Mellow Hope's MedVac flu vaccine products. The company intends to participate in a formal tender process to supply a couple separate orders to a couple separate and unrelated entities in Chile.
Medsphere Systems Corporation, the leading provider of open-source healthcare enterprise solutions, today voiced support for the official "meaningful use" requirements released by the Department of Health and Human Services' Office of the National Coordinator for Health IT. These recently announced requirements will be used to determine hospitals' eligibility for millions in American Recovery and Reinvestment Act stimulus funds associated with deploying health IT solutions to improve patient care.
The National Association For Continence (NAFC) is heading a newly formed council with the objective of establishing national, independent quality standards for disposable adult absorbent products provided by states to Medicaid waiver recipients cared for in their private homes rather than as residents of a state-funded nursing home.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that it has granted Novartis an option to obtain an exclusive worldwide license to develop and commercialize its p53 temporary inhibitor siRNA drug QPI-1002, currently the subject of a Phase II clinical trial.
› Verified 4 days ago
| Entity Name | Island Medical Loe Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457636706 PECOS PAC ID: 3274700323 Enrollment ID: O20120113000095 |
News Archive
Hard to Treat Diseases, Inc. subsidiary, Shenzhen Mellow Hope Pharm Industrial Co., Ltd. (Mellow Hope) announced today that the general manager of Mellow Hope paid a visit to Chile, in regards to a significant new business development opportunity related to Mellow Hope's MedVac flu vaccine products. The company intends to participate in a formal tender process to supply a couple separate orders to a couple separate and unrelated entities in Chile.
Medsphere Systems Corporation, the leading provider of open-source healthcare enterprise solutions, today voiced support for the official "meaningful use" requirements released by the Department of Health and Human Services' Office of the National Coordinator for Health IT. These recently announced requirements will be used to determine hospitals' eligibility for millions in American Recovery and Reinvestment Act stimulus funds associated with deploying health IT solutions to improve patient care.
The National Association For Continence (NAFC) is heading a newly formed council with the objective of establishing national, independent quality standards for disposable adult absorbent products provided by states to Medicaid waiver recipients cared for in their private homes rather than as residents of a state-funded nursing home.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that it has granted Novartis an option to obtain an exclusive worldwide license to develop and commercialize its p53 temporary inhibitor siRNA drug QPI-1002, currently the subject of a Phase II clinical trial.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Darryl Macias, MD Rehoboth Mckinley Christian Health Care Services, 1901 Red Rock Drive, Gallup, NM 87301 Ph: (505) 863-7000 | Darryl Macias, MD Rehoboth Mckinley Christian Health Care Services, 1901 Red Rock Drive, Gallup, NM 87301 Ph: (505) 863-7000 |
News Archive
Hard to Treat Diseases, Inc. subsidiary, Shenzhen Mellow Hope Pharm Industrial Co., Ltd. (Mellow Hope) announced today that the general manager of Mellow Hope paid a visit to Chile, in regards to a significant new business development opportunity related to Mellow Hope's MedVac flu vaccine products. The company intends to participate in a formal tender process to supply a couple separate orders to a couple separate and unrelated entities in Chile.
Medsphere Systems Corporation, the leading provider of open-source healthcare enterprise solutions, today voiced support for the official "meaningful use" requirements released by the Department of Health and Human Services' Office of the National Coordinator for Health IT. These recently announced requirements will be used to determine hospitals' eligibility for millions in American Recovery and Reinvestment Act stimulus funds associated with deploying health IT solutions to improve patient care.
The National Association For Continence (NAFC) is heading a newly formed council with the objective of establishing national, independent quality standards for disposable adult absorbent products provided by states to Medicaid waiver recipients cared for in their private homes rather than as residents of a state-funded nursing home.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that it has granted Novartis an option to obtain an exclusive worldwide license to develop and commercialize its p53 temporary inhibitor siRNA drug QPI-1002, currently the subject of a Phase II clinical trial.
› Verified 4 days ago
Mehdi Sattari, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: Rehoboth Mckinley Christian Health Care Services, 1901 Red Rock Drive, Gallup, NM 87301 Phone: 505-863-7000 | |
Alan Craig Beamsley, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1010 Milda Ave, Gallup, NM 87301 Phone: 505-870-1256 | |
Faye Maryann Lee, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: Gimc Department Of Emergency Medicine, 516 Nizhoni Blvd, Gallup, NM 87301 Phone: 714-785-5263 | |
Alexander Miles Jenson, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 516 E Nizhoni Blvd, Gallup, NM 87301 Phone: 781-301-1077 | |
Mac Henry, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 516 E Nizhoni Blvd, Gallup, NM 87301 Phone: 505-722-1000 | |
Clayton M Dalton, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 516 E Nizhoni Blvd, Gallup, NM 87301 Phone: 505-722-1000 |